| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ACBAurora Cannabis Inc. | 239.88M | 4.24 | 148.77 | 27.01% | 7.68% | 4.54% | 0.17 | |
| IXHLIncannex Healthcare Limited | 132.26M | 0.38 | -0.28 | 378.7% | -1671.96% | -466.4% | 0.02 | |
| TLRYTilray Brands, Inc. | 1.13B | 9.71 | -0.29 | 4.84% | -252.55% | -136.55% | 0.22 | |
| IMCCIM Cannabis Corp. | 7.08M | 1.35 | -0.30 | 10.71% | -8.96% | -109.13% | 5.73 | |
| AKANAkanda Corp. | 190.81K | 1.31 | -0.33 | -61.27% | -12.14% | -8.5% | 0.08 | |
| INCRInterCure Ltd. | 52M | 0.95 | -0.67 | -32.82% | -28.38% | -17.05% | 0.53 | |
| FLGCFlora Growth Corp. | 6.84M | 6.54 | -5.03 | -21.78% | -32.14% | -24.58% | 1.09 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 216.74K | 743.58K | 825.33K | 415.63K | 1.43M | 0 | 0 | 17.96K | 86K |
| Revenue Growth % | - | - | 2.43% | 0.11% | -0.5% | 2.43% | -1% | - | - | 3.79% |
| Cost of Goods Sold | 0 | 396.9K | 384.98K | 407.74K | 309.44K | 685.2K | 4.36K | 0 | 0 | 0 |
| COGS % of Revenue | - | 1.83% | 0.52% | 0.49% | 0.74% | 0.48% | - | - | - | - |
| Gross Profit | 0 | -180.17K | 358.59K | 417.58K | 106.19K | 740.54K | -4.36K | 0 | 17.96K | 86K |
| Gross Margin % | - | -0.83% | 0.48% | 0.51% | 0.26% | 0.52% | - | - | 1% | 1% |
| Gross Profit Growth % | - | - | 2.99% | 0.16% | -0.75% | 5.97% | -1.01% | 1% | - | 3.79% |
| Operating Expenses | 577.22K | 15.92M | 2.72M | 2.37M | 2.96M | 9.31M | -4.36K | 13.64M | 44.99M | 23.88M |
| OpEx % of Revenue | - | 73.47% | 3.66% | 2.87% | 7.11% | 6.53% | - | - | 2504.42% | 277.62% |
| Selling, General & Admin | 383.57K | 2.11M | 2.68M | 1.83M | 1.51M | 5.77M | 7M | 7.92M | 25.56M | 13.13M |
| SG&A % of Revenue | - | 9.71% | 3.61% | 2.21% | 3.62% | 4.05% | - | - | 1422.58% | 152.65% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 3.57M | 3.7M | 6.31M | 19.28M | 10.75M |
| R&D % of Revenue | - | - | - | - | - | 2.5% | - | - | 1073.25% | 124.97% |
| Other Operating Expenses | 193.65K | 13.82M | 40.13K | 544.88K | 1.45M | -28.18K | -10.7M | -595K | 154.2K | 0 |
| Operating Income | -577.22K | -16.1M | -2.36M | -1.95M | -2.85M | -8.57M | -10.16M | -13.64M | -44.97M | -23.79M |
| Operating Margin % | - | -74.3% | -3.18% | -2.37% | -6.85% | -6.01% | - | - | -2503.42% | -276.62% |
| Operating Income Growth % | 0.7% | -26.9% | 0.85% | 0.17% | -0.46% | -2.01% | -0.19% | -0.34% | -2.3% | 0.47% |
| EBITDA | -599.81K | -16.08M | -2.32M | -1.92M | -2.81M | -8.57M | -10.16M | -13.55M | -44.82M | -23.54M |
| EBITDA Margin % | - | -74.19% | -3.13% | -2.33% | -6.77% | -6.01% | - | - | -2494.83% | -273.76% |
| EBITDA Growth % | 0.68% | -25.81% | 0.86% | 0.17% | -0.46% | -2.05% | -0.19% | -0.33% | -2.31% | 0.47% |
| D&A (Non-Cash Add-back) | 0 | 23.71K | 40.13K | 29.33K | 36.54K | 0 | 0 | 88K | 154.2K | 246K |
| EBIT | -599.81K | -16.1M | -2.35M | -1.95M | -2.85M | -8.57M | -10.16M | -13.64M | -27.86M | -48.34M |
| Net Interest Income | -52.27K | -31.03K | -4.42K | -58.43K | 3.12K | 2.01K | 4.31K | 241K | 308.4K | -241K |
| Interest Income | 8.54K | 7.24K | 5.04K | 1.14K | 3.12K | 2.01K | 4.31K | 241K | 308.4K | 62K |
| Interest Expense | 60.81K | 38.27K | 9.46K | 59.57K | 0 | 0 | 0 | 0 | 0 | 303K |
| Other Income/Expense | -83.41K | -31.03K | 4.96K | -57.17K | 149.22K | 28.74K | -88.3K | -35.17M | 17.38M | -23.1M |
| Pretax Income | -660.63K | -16.13M | -2.36M | -2.01M | -2.7M | -8.54M | -10.25M | -48.81M | -27.59M | -46.88M |
| Pretax Margin % | - | -74.44% | -3.17% | -2.44% | -6.5% | -5.99% | - | - | -1535.75% | -545.17% |
| Income Tax | -68.73K | -234.15K | -193.4K | -105.98K | 0 | 0 | 0 | 0 | 44.91K | 0 |
| Effective Tax Rate % | 0.9% | 0.99% | 0.92% | 0.95% | 1.2% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -591.89K | -15.9M | -2.17M | -1.9M | -3.23M | -8.54M | -10.25M | -48.81M | -27.63M | -46.88M |
| Net Margin % | - | -73.36% | -2.91% | -2.31% | -7.77% | -5.99% | - | - | -1538.25% | -545.17% |
| Net Income Growth % | 0.7% | -25.86% | 0.86% | 0.12% | -0.7% | -1.65% | -0.2% | -3.76% | 0.43% | -0.7% |
| Net Income (Continuing) | -591.89K | -15.9M | -2.17M | -1.9M | -2.7M | -8.54M | -10.25M | -48.81M | -27.63M | -46.88M |
| Discontinued Operations | 0 | 0 | 0 | 0 | -527.95K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | -0.50 | -0.04 | -0.01 | -0.02 | -0.03 | -0.03 | -3.17 | -1.14 | -1.36 |
| EPS Growth % | 0.79% | -13.29% | 0.92% | 0.77% | - | -1.19% | 0.01% | -90.62% | 0.64% | -0.19% |
| EPS (Basic) | -0.04 | -0.50 | -0.04 | -0.01 | -0.02 | -0.03 | -0.03 | -3.17 | -1.14 | -1.36 |
| Diluted Shares Outstanding | 15.69M | 31.91M | 57M | 111.86M | 171.01M | 244.5M | 297.79M | 15.38M | 16.16M | 34.45M |
| Basic Shares Outstanding | 15.69M | 31.91M | 57M | 111.86M | 171.01M | 244.5M | 297.79M | 15.38M | 16.16M | 34.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 85.22K | 645.15K | 399.02K | 268.96K | 2.92M | 7M | 26.15M | 23M | 16.2M | 19.96M |
| Cash & Short-Term Investments | 3.41K | 389.6K | 169.05K | 65.52K | 2.49M | 6.84M | 25.8M | 22.12M | 5.86M | 15.04M |
| Cash Only | 3.41K | 389.6K | 169.05K | 65.52K | 2.49M | 6.85M | 25.8M | 22.12M | 5.86M | 15.04M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.27K | 6.22K | 7.71K | 58.92K | 283.96K | 127.04K | 219.33K | 191K | 10.02M | 4.63M |
| Days Sales Outstanding | - | 10.47 | 3.79 | 26.06 | 249.37 | 32.52 | - | - | 203.48K | 19.63K |
| Inventory | 43.44K | 174.15K | 164.82K | 107.23K | 125.85K | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 160.15 | 156.26 | 95.99 | 148.45 | - | - | - | - | - |
| Other Current Assets | 34.08K | 74.83K | 53.19K | 33.95K | 19.21K | -251 | 94.84K | 0 | 0 | 0 |
| Total Non-Current Assets | 172.16K | 123.57K | 124.89K | 94.64K | 0 | 0 | 0 | 786K | 845K | 485K |
| Property, Plant & Equipment | 18.45K | 33.85K | 72.3K | 59.97K | 0 | 0 | 0 | 786K | 845K | 485K |
| Fixed Asset Turnover | - | 6.40x | 10.29x | 13.76x | - | - | - | - | 0.02x | 0.18x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 153.7K | 89.72K | 52.6K | 34.66K | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 257.38K | 768.72K | 523.91K | 363.6K | 2.92M | 7M | 26.15M | 23.78M | 17.05M | 20.45M |
| Asset Turnover | - | 0.28x | 1.42x | 2.27x | 0.14x | 0.20x | - | - | 0.00x | 0.00x |
| Asset Growth % | -0.95% | 1.99% | -0.32% | -0.31% | 7.04% | 1.39% | 2.74% | -0.09% | -0.28% | 0.2% |
| Total Current Liabilities | 779.96K | 593.01K | 807.62K | 656.48K | 736.35K | 567.3K | 1.39M | 2.55M | 5.62M | 6.98M |
| Accounts Payable | 105.89K | 411.72K | 366.37K | 264.06K | 405.47K | 174.8K | 898.02K | 1.75M | 527K | 6.07M |
| Days Payables Outstanding | - | 378.63 | 347.35 | 236.38 | 478.27 | 93.12 | 75.2K | - | - | - |
| Short-Term Debt | 521.47K | 0 | 148.03K | 45.63K | 0 | 0 | 0 | 0 | 163K | 184K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 85K | 0 |
| Other Current Liabilities | 152.59K | 0 | 146.33K | 274.69K | 77.27K | 105.35K | 204.29K | 263K | 170K | 726K |
| Current Ratio | 0.11x | 1.09x | 0.49x | 0.41x | 3.97x | 12.33x | 18.84x | 9.02x | 2.88x | 2.86x |
| Quick Ratio | 0.05x | 0.79x | 0.29x | 0.25x | 3.80x | 12.33x | 18.84x | 9.02x | 2.88x | 2.86x |
| Cash Conversion Cycle | - | -208 | -187.3 | -114.33 | -80.45 | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 305.48K | 0 | 0 | 0 | 0 | 0 | 408K | 210K | 74K |
| Long-Term Debt | 0 | 305.48K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 408K | 210K | 74K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 779.95K | 898.49K | 807.62K | 656.48K | 736.35K | 566.17K | 1.39M | 2.96M | 5.83M | 7.06M |
| Total Debt | 521.47K | 305.48K | 148.03K | 45.63K | 0 | 0 | 0 | 521K | 373K | 258K |
| Net Debt | 518.06K | -84.12K | -21.02K | -19.89K | -2.49M | -6.84M | -25.89M | -21.6M | -5.49M | -14.78M |
| Debt / Equity | - | - | - | - | - | - | - | 0.03x | 0.03x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -9.49x | -420.78x | -249.78x | -32.78x | - | - | - | - | - | -78.51x |
| Total Equity | -522.58K | -129.77K | -283.71K | -292.88K | 2.18M | 6.43M | 24.76M | 20.82M | 11.22M | 13.39M |
| Equity Growth % | -2.44% | 0.75% | -1.19% | -0.03% | 8.46% | 1.94% | 2.85% | -0.16% | -0.46% | 0.19% |
| Book Value per Share | -0.03 | -0.00 | -0.00 | -0.00 | 0.01 | 0.03 | 0.08 | 1.35 | 0.69 | 0.39 |
| Total Shareholders' Equity | -522.58K | -129.77K | -283.71K | -292.88K | 2.17M | 6.44M | 24.76M | 20.82M | 11.22M | 13.39M |
| Common Stock | 81.07K | 16.71M | 18.07M | 18.91M | 23.54M | 34.38M | 59.54M | 2K | 2K | 20K |
| Retained Earnings | -603.65K | -16.97M | -18.52M | -19.53M | -22.44M | -32.98M | -40.59M | -92.21M | -110.67M | -157.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 1.03M | 4.96M | 0 | -3.25M | -3.33M | -3.12M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -491.77K | -2.06M | -2.11M | -1.52M | -2.7M | -5.18M | -8.84M | -10.75M | -15.85M | -12.51M |
| Operating CF Margin % | - | -9.52% | -2.84% | -1.84% | -6.49% | -3.63% | - | - | -881.98% | -145.5% |
| Operating CF Growth % | 0.5% | -3.2% | -0.02% | 0.28% | -0.78% | -0.92% | -0.71% | -0.22% | -0.47% | 0.21% |
| Net Income | -549.82K | -15.6M | -2.18M | -1.91M | -3.24M | -8.54M | -10.25M | -48.81M | -18.46M | -46.88M |
| Depreciation & Amortization | 11.65K | 13.82M | 42.33K | 0 | 0 | 0 | 0 | 88K | 103K | 246K |
| Stock-Based Compensation | 0 | 112.5K | 50.92K | 33.59K | 390.23K | 449.94K | 1.01M | 2.15M | 8.93M | 2.61M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 115.92K | -232.73K | -47.48K | 317.85K | 412.69K | 2.91M | 319.36K | 36.45M | 3.05M | 24.74M |
| Working Capital Changes | -69.52K | -159.66K | 26K | 40.27K | -257.51K | 4.33K | 79.6K | -626K | -9.47M | 6.78M |
| Change in Receivables | -32.77K | -39.64K | 28.92K | -30.67K | 0 | 161.46K | -63.74K | 0 | 0 | 0 |
| Change in Inventory | -36.75K | -129.66K | -2.92K | 49.33K | 0 | 137.61K | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.39M |
| Cash from Investing | -143.62K | 2.31M | -35.23K | -17.16K | 8.93K | 22K | 0 | -316K | -277K | -8K |
| Capital Expenditures | -7.1K | -37.8K | -35.23K | -17.16K | 0 | 0 | 0 | -316K | -277K | -8K |
| CapEx % of Revenue | - | 0.17% | 0.05% | 0.02% | - | 0% | - | - | 15.42% | 0.09% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -136.52K | -723 | 0 | 0 | 8.93K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 638.38K | 140.28K | 1.94M | 1.44M | 5.11M | 9.3M | 28.33M | 8.18M | 0 | 21.4M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -224 | 8.12K | 2.09M | 1.53M | 5.15M | 48.43K | -1.54M | 36.22K | 0 | -24.77M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -498.87K | -2.1M | -2.15M | -1.53M | -2.7M | -5.18M | -8.84M | -11.06M | -16.12M | -12.52M |
| FCF Margin % | - | -9.7% | -2.89% | -1.86% | -6.49% | -3.63% | - | - | -897.4% | -145.59% |
| FCF Growth % | 0.49% | -3.21% | -0.02% | 0.29% | -0.76% | -0.92% | -0.71% | -0.25% | -0.46% | 0.22% |
| FCF per Share | -0.03 | -0.07 | -0.04 | -0.01 | -0.02 | -0.02 | -0.03 | -0.72 | -1.00 | -0.36 |
| FCF Conversion (FCF/Net Income) | 0.83x | 0.13x | 0.97x | 0.80x | 0.84x | 0.61x | 0.86x | 0.22x | 0.57x | 0.27x |
| Interest Paid | 100 | 439 | 0 | 64.76K | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | - | -341.39% | -198.42% | -65.73% | -214.13% | -172.49% | -381.09% |
| Return on Invested Capital (ROIC) | -87.63% | - | - | - | - | - | - | - | -1360.66% | -822.2% |
| Gross Margin | - | -83.13% | 48.23% | 50.6% | 25.55% | 51.94% | - | - | 100% | 100% |
| Net Margin | - | -7336.21% | -291.24% | -230.67% | -776.62% | -599.33% | - | - | -153824.99% | -54517.44% |
| Debt / Equity | - | - | - | - | - | - | - | 0.03x | 0.03x | 0.02x |
| Interest Coverage | -9.49x | -420.78x | -249.78x | -32.78x | - | - | - | - | - | -78.51x |
| FCF Conversion | 0.83x | 0.13x | 0.97x | 0.80x | 0.84x | 0.61x | 0.86x | 0.22x | 0.57x | 0.27x |
| Revenue Growth | - | - | 243.08% | 10.99% | -49.64% | 243.03% | -100% | - | - | 378.7% |
Incannex Healthcare Limited (IXHL) reported $0.0M in revenue for fiscal year 2025. This represents a 45% decrease from $0.1M in 2012.
Incannex Healthcare Limited (IXHL) grew revenue by 378.7% over the past year. This is strong growth.
Incannex Healthcare Limited (IXHL) reported a net loss of $62.4M for fiscal year 2025.
Incannex Healthcare Limited (IXHL) has a return on equity (ROE) of -381.1%. Negative ROE indicates the company is unprofitable.
Incannex Healthcare Limited (IXHL) had negative free cash flow of $14.7M in fiscal year 2025, likely due to heavy capital investments.